Key result
Type 2 diabetes linked to ~5.6-fold higher odds of atypical chest discomfort in NSTE-ACS.
Why the study?
The epidemiological-clinical and paraclinical particularities of NSTE-ACS in Malagasy patients with type 2 diabetes mellitus were not well defined.
Does type 2 diabetes mellitus alter the clinical and paraclinical presentation of NSTE-ACS in patients in Madagascar?
Observational (n=130)
No
Does type 2 diabetes mellitus alter the clinical and paraclinical presentation of NSTE-ACS in patients in Madagascar?
NSTE-ACS in diabetic patients frequently presents with atypical clinical symptoms and higher disease severity, underscoring the need for early recognition and comprehensive risk factor management.
Answers are grounded in this paper and cite their sources.
May warrant clinical awareness of atypical NSTE-ACS symptoms in type 2 diabetes; leaves open generalizability and diagnostic impact in prospective studies.
INTRODUCTION: This study aimed at determining the epidemiological-clinical and paraclinical particularities of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in Malagasy with type 2 diabetes mellitus (T2DM). METHODS: This was a retrospective, descriptive and comparative study between patients with and without T2DM, carried out over a period of 38 months. The diagnosis of NSTE-ACS was retained in front of the association of chest discomfort, electrical abnormalities and elevations beyond fivefold the upper reference limit of high-sensitivity cardiac troponin. RESULT: With 130 patients included, the overall prevalence of NSTE-ACS was 4.1%, of which 68 patients (52.3%) had T2DM. Compared to without T2DM, NSTE-ACS in T2DM was characterized by young age (p = .0002), high-frequency hypertension (OR 2.92 [1.23-7.25]; p = .0041), overweight/obesity (OR 4.39 [1.72-12.4]; p = .0002) and microalbuminuria (p < .0001), accelerated heart rate (p = .0104), atypical chest discomfort (OR 5.57 [2.21-15.7]; p < .0001), pulmonary crepitations (OR 2.25 [1.02-5.14]; p = .0224), high GRACE score (p = .0016), damage of extensive anterior leads (OR 2.11 [1.02-4.98]; p = .0402) and septal lead (OR 3.64 [1.41-10.3]; p = .0015), significant increase in cardiac troponin (p < .0001), high left ventricular filling pressure (OR 3.39 [1.51-7.90]; p = .001). CONCLUSION: NSTE-ACS in T2DM is frequent, with an atypical clinical and severe paraclinical presentations. Adequate and multidisciplinary management of cardiovascular risk factors, including T2DM, could thus minimize the occurrence of NSTE-ACS and improve this profile.
No takes yet. Share an insight, caveat, or question.
Raharinavalona et al. (2022) conducted an observational in Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) (n=130). Type 2 diabetes mellitus vs. Absence of type 2 diabetes mellitus was evaluated on Atypical chest discomfort (OR 5.57, 95% CI 2.21-15.7, p=<0.0001). In patients with NSTE-ACS, the presence of type 2 diabetes was significantly associated with an atypical presentation of chest discomfort (OR 5.57) compared to patients without diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: